Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Workday
WDAY
5
eBay
EBAY
US Stock MarketDetailed Quotes
STOK Stoke Therapeutics
- 9.510
- +0.040+0.42%
Close Apr 29 16:00 ET
- 9.300
- -0.210-2.21%
Pre 06:53 ET
519.22MMarket Cap-5.76P/E (TTM)
9.575High9.130Low750.74KVolume9.520Open9.470Pre Close7.02MTurnover1.99%Turnover RatioLossP/E (Static)54.60MShares17.58052wk High2.27P/B358.17MFloat Cap5.35052wk Low--Dividend TTM37.66MShs Float71.580Historical High--Div YieldTTM4.70%Amplitude3.350Historical Low9.356Avg Price1Lot Size
Stoke Therapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | 7.70%216.9M | 7.70%216.9M | 11.40%239.2M | 21.83%281.98M | -29.60%178.58M | -12.28%201.39M | -12.28%201.39M | -14.68%214.72M | -16.03%231.45M | -13.49%253.67M |
| -Cash and cash equivalents | -33.15%127.98M | -33.15%127.98M | -21.03%150.02M | 0.74%193.48M | -6.18%178.58M | 68.59%191.44M | 68.59%191.44M | 67.53%189.98M | 183.47%192.06M | 126.30%190.34M |
| -Short-term investments | 793.45%88.92M | 793.45%88.92M | 260.47%89.18M | 124.71%88.51M | --0 | -91.42%9.95M | -91.42%9.95M | -82.11%24.74M | -81.05%39.39M | -69.71%63.33M |
| Receivables | 993.75%700K | 993.75%700K | 619.79%691K | 124.26%305K | -97.76%11K | -89.12%64K | -89.12%64K | -75.70%96K | -61.14%136K | 85.66%492K |
| -Accrued interest receivable | 993.75%700K | 993.75%700K | 619.79%691K | 124.26%305K | -97.76%11K | -89.12%64K | -89.12%64K | -75.70%96K | -61.14%136K | 85.66%492K |
| Prepaid assets | -1.79%11.12M | -1.79%11.12M | -10.05%9.84M | -5.53%10.35M | 5.21%10.72M | 3.55%11.32M | 3.55%11.32M | -12.87%10.94M | -16.91%10.95M | -17.08%10.19M |
| Restricted cash | --75K | --75K | --75K | --75K | ---- | --0 | --0 | ---- | ---- | ---- |
| Current deferred assets | ---- | ---- | ---- | ---- | --402K | ---- | ---- | ---- | ---- | ---- |
| Other current assets | 54.82%3.97M | 54.82%3.97M | -10.78%3.81M | 15.90%4.29M | -39.47%3.56M | -13.33%2.56M | -13.33%2.56M | --4.27M | --3.7M | --5.88M |
| Total current assets | 8.09%232.76M | 8.09%232.76M | 10.26%253.61M | 20.62%296.99M | -28.48%193.28M | -11.77%215.34M | -11.77%215.34M | -13.07%230.02M | -14.85%246.23M | -11.62%270.24M |
| Non current assets | ||||||||||
| Net PPE | -33.62%8.25M | -33.62%8.25M | -0.43%9.26M | 1.49%10.27M | 3.16%11.34M | 8.80%12.43M | 8.80%12.43M | -25.33%9.3M | -13.51%10.12M | 14.51%10.99M |
| -Gross PPE | -10.48%17.1M | -10.48%17.1M | -0.43%9.26M | 1.49%10.27M | 3.16%11.34M | 22.19%19.11M | 22.19%19.11M | -25.33%9.3M | -13.51%10.12M | 14.51%10.99M |
| -Accumulated depreciation | -32.63%-8.85M | -32.63%-8.85M | ---- | ---- | ---- | -58.57%-6.67M | -58.57%-6.67M | ---- | ---- | ---- |
| Investments and advances | --29.82M | --29.82M | --29.95M | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| Other non current assets | 26.71%721K | 26.71%721K | -13.18%494K | -13.18%494K | 0.00%569K | 0.00%569K | 0.00%569K | 0.00%569K | 0.00%569K | 0.00%569K |
| Total non current assets | 198.38%38.8M | 198.38%38.8M | 302.30%39.71M | 0.71%10.76M | 3.00%11.91M | 8.39%13M | 8.39%13M | -24.22%9.87M | -12.89%10.69M | 13.70%11.56M |
| Total assets | 18.92%271.56M | 18.92%271.56M | 22.27%293.32M | 19.79%307.76M | -27.19%205.18M | -10.83%228.34M | -10.83%228.34M | -13.59%239.89M | -14.77%256.92M | -10.81%281.8M |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Payables | 47.37%2.5M | 47.37%2.5M | -19.21%2.49M | 153.53%3.95M | -51.10%2.1M | 121.28%1.7M | 121.28%1.7M | 60.96%3.08M | -56.80%1.56M | 29.18%4.3M |
| -accounts payable | 47.37%2.5M | 47.37%2.5M | -19.21%2.49M | 153.53%3.95M | -51.10%2.1M | 121.28%1.7M | 121.28%1.7M | 60.96%3.08M | -56.80%1.56M | 29.18%4.3M |
| Current accrued expenses | 47.70%7.81M | 47.70%7.81M | 22.94%6.97M | 29.62%7.65M | -17.28%7.72M | -25.83%5.29M | -25.83%5.29M | -19.19%5.67M | -22.53%5.9M | 21.19%9.34M |
| Current debt and capital lease obligation | 12.61%2.32M | 12.61%2.32M | -8.01%2.3M | -7.06%2.28M | -7.95%2.21M | -12.59%2.06M | -12.59%2.06M | 8.00%2.5M | 17.79%2.45M | 56.61%2.4M |
| -Current capital lease obligation | 12.61%2.32M | 12.61%2.32M | -8.01%2.3M | -7.06%2.28M | -7.95%2.21M | -12.59%2.06M | -12.59%2.06M | 8.00%2.5M | 17.79%2.45M | 56.61%2.4M |
| Current deferred liabilities | 24.05%18.99M | 24.05%18.99M | 261.90%31.61M | 223.25%26.05M | 55.51%20.92M | 2.88%15.31M | 2.88%15.31M | -31.96%8.74M | -24.21%8.06M | 58.83%13.45M |
| Other current liabilities | -12.14%753K | -12.14%753K | 26.48%597K | 47.51%1.04M | 93.68%980K | 68.37%857K | 68.37%857K | 10.80%472K | -6.27%703K | -3.25%506K |
| Current liabilities | 29.97%40.06M | 29.97%40.06M | 97.87%49.87M | 103.76%44.5M | 12.89%35.59M | -1.83%30.82M | -1.83%30.82M | -12.48%25.2M | -21.02%21.84M | 37.64%31.53M |
| Non current liabilities | ||||||||||
| Non current deferred liabilities | --0 | --0 | -79.64%8.29M | -60.83%16.95M | -26.66%25.04M | -10.26%33.07M | -10.26%33.07M | -0.85%40.73M | -4.32%43.26M | -31.08%34.14M |
| Other non current liabilities | -49.26%2.48M | -49.26%2.48M | 218.04%3.05M | 121.36%3.61M | 82.72%4.21M | 64.56%4.88M | 64.56%4.88M | -73.43%959K | -61.64%1.63M | -34.41%2.3M |
| Total non current liabilities | -93.47%2.48M | -93.47%2.48M | -72.80%11.34M | -54.21%20.55M | -19.75%29.25M | -4.69%37.96M | -4.69%37.96M | -6.71%41.69M | -9.24%44.89M | -31.30%36.45M |
| Total liabilities | -38.16%42.53M | -38.16%42.53M | -8.50%61.21M | -2.51%65.05M | -4.61%64.84M | -3.43%68.78M | -3.43%68.78M | -8.97%66.89M | -13.46%66.72M | -10.51%67.97M |
| Shareholders'equity | ||||||||||
| Share capital | 0.00%5K | 0.00%5K | 25.00%5K | 25.00%5K | 25.00%5K | 25.00%5K | 25.00%5K | 0.00%4K | 0.00%4K | 0.00%4K |
| -common stock | 0.00%5K | 0.00%5K | 25.00%5K | 25.00%5K | 25.00%5K | 25.00%5K | 25.00%5K | 0.00%4K | 0.00%4K | 0.00%4K |
| Retained earnings | -22.14%-490.83M | -22.14%-490.83M | -28.13%-480.35M | -29.56%-453.92M | -33.95%-428.22M | -35.23%-401.85M | -35.23%-401.85M | -38.08%-374.89M | -42.78%-350.35M | -44.83%-319.7M |
| Paid-in capital | 28.24%720M | 28.24%720M | 29.97%712.29M | 28.79%696.64M | 6.45%568.56M | 16.20%561.43M | 16.20%561.43M | 14.81%548.03M | 14.85%540.92M | 15.76%534.11M |
| Gains losses not affecting retained earnings | -529.17%-151K | -529.17%-151K | 212.93%166K | 96.04%-15K | --0 | 97.96%-24K | 97.96%-24K | 91.37%-147K | 70.30%-379K | 12.57%-598K |
| Total stockholders'equity | 43.53%229.02M | 43.53%229.02M | 34.17%232.11M | 27.61%242.71M | -34.37%140.34M | -13.68%159.57M | -13.68%159.57M | -15.26%173M | -15.21%190.2M | -10.90%213.82M |
| Total equity | 43.53%229.02M | 43.53%229.02M | 34.17%232.11M | 27.61%242.71M | -34.37%140.34M | -13.68%159.57M | -13.68%159.57M | -15.26%173M | -15.21%190.2M | -10.90%213.82M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Market Insights
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
